BackNewron Pharmaceuticals S.p.A. Overview

Newron Pharmaceuticals S.p.A. Current Assets

Newron Pharmaceuticals S.p.A.'s current assets is $40M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$39.61M
↓ 34.50% YoYΔ $-20.86M vs prior year quarter

Peer trimmed avg / median

Loading

Newron Pharmaceuticals S.p.A. Current Assets History

Loading

Newron Pharmaceuticals S.p.A. vs. peers: Current Assets Comparison

Loading

Newron Pharmaceuticals S.p.A. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Newron Pharmaceuticals S.p.A. (NP5.DE) FAQ

The latest current assets for NP5.DE is $40M as of June 2026. That compares with $60M in the prior-year period — down 34.5% year over year. Investors often review this figure alongside Newron Pharmaceuticals S.p.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NP5.DE's current assets moved from $60M to $40M — a 34.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Newron Pharmaceuticals S.p.A.'s operating scale or balance-sheet position.

A current assets figure of $40M for NP5.DE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NP5.DE's current assets ($40M), review year-over-year change from $60M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Newron Pharmaceuticals S.p.A.'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.